DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 Mar, 2024, 16:01 ET – Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis – Webcast of Earnings Call Today, March 27th at 4:30 p.m. ET CUPERTINO, Calif., March 27, 2024 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and year ended December […]